Avelumab tolerable for patients according to JAVELIN Solid Tumor phase Ib trial

Dr. Andrea B. Apolo, MD of the National Cancer Institute discusses how Avelumab is tolerable for patients according to JAVELIN Solid Tumor phase Ib trial at ASCO GU 2016.